The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

William F. Anderson

Corresponding author: William F. Anderson

Division of Cancer Epidemiology and Genetics

National Cancer Institute

Biostatistics Branch



Name/email consistency: high



  • Corresponding author: William F. Anderson, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Biostatistics Branch, MD. 2001 - 2011
  • Biostatistics Branch (BB), DHHS/NIH/NCI/Division of Cancer Epidemiology and Genetics (DCEG), EPS, Room 8036, 6120 Executive Blvd, USA. 2005 - 2010
  • NIH/NCI/DCEG, EPS Room 8036, 6120 Executive Blvd, Bethesda, USA. 2009
  • Biostatistics Branch, DHHS/NIH/NCI/DCEG, EPS, Bethesda, MD 20892-7244, USA. 2007
  • National Cancer Institute, Division of Cancer Prevention, EPN, Room 2144, 6130 Executive Blvd, USA. 2003 - 2005
  • DHHS/NIH/NCI/DCP, Rockville, MD 20852-7244, USA. 2005
  • Division of Cancer Prevention/Gastrointestinal and Other Cancer Research Group, National Cancer Institute, Bethesda, MD 20892-7117, USA. 2002 - 2004
  • NCI/Division of Cancer Prevention, EPN, Bethesda, MD 20892-7317, USA. 2002 - 2004


  1. Incidence of breast cancer in the United States: current and future trends. Anderson, W.F., Katki, H.A., Rosenberg, P.S. J. Natl. Cancer Inst. (2011) [Pubmed]
  2. Male breast cancer: a population-based comparison with female breast cancer. Anderson, W.F., Jatoi, I., Tse, J., Rosenberg, P.S. J. Clin. Oncol. (2010) [Pubmed]
  3. Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program. Anderson, W.F., Luo, S., Chatterjee, N., Rosenberg, P.S., Matsuno, R.K., Goodman, M.T., Hernandez, B.Y., Reichman, M., Dolled-Filhart, M.P., O'Regan, R.M., Garcia-Closas, M., Perou, C.M., Jatoi, I., Cartun, R.W., Sherman, M.E. Breast Cancer Res. Treat. (2009) [Pubmed]
  4. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Anderson, W.F., Pfeiffer, R.M., Tucker, M.A., Rosenberg, P.S. Cancer (2009) [Pubmed]
  5. Age-related crossover in breast cancer incidence rates between black and white ethnic groups. Anderson, W.F., Rosenberg, P.S., Menashe, I., Mitani, A., Pfeiffer, R.M. J. Natl. Cancer Inst. (2008) [Pubmed]
  6. Shifting breast cancer trends in the United States. Anderson, W.F., Reiner, A.S., Matsuno, R.K., Pfeiffer, R.M. J. Clin. Oncol. (2007) [Pubmed]
  7. Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Anderson, W.F., Chen, B.E., Brinton, L.A., Devesa, S.S. Cancer. Causes. Control (2007) [Pubmed]
  8. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Anderson, W.F., Matsuno, R.K., Sherman, M.E., Lissowska, J., Gail, M.H., Brinton, L.A., Yang, X.R., Peplonska, B., Chen, B.E., Rosenberg, P.S., Chatterjee, N., Szeszenia-Dabrowska, N., Bardin-Mikolajczak, A., Zatonski, W., Devesa, S.S., García-Closas, M. Cancer. Causes. Control (2007) [Pubmed]
  9. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002). Anderson, W.F., Jatoi, I., Devesa, S.S. Breast Cancer Res. Treat. (2006) [Pubmed]
  10. Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. Anderson, W.F., Chen, B.E., Jatoi, I., Rosenberg, P.S. Breast Cancer Res. Treat. (2006) [Pubmed]
  11. Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Anderson, W.F., Pfeiffer, R.M., Dores, G.M., Sherman, M.E. Cancer Epidemiol. Biomarkers Prev. (2006) [Pubmed]
  12. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Anderson, W.F., Jatoi, I., Devesa, S.S. Breast Cancer Res. Treat. (2005) [Pubmed]
  13. In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute. Anderson, W.F., Devesa, S.S. Cancer (2005) [Pubmed]
  14. Epidemiology of inflammatory breast cancer (IBC). Anderson, W.F., Schairer, C., Chen, B.E., Hance, K.W., Levine, P.H. Breast. Dis (2005) [Pubmed]
  15. Is male breast cancer similar or different than female breast cancer?. Anderson, W.F., Althuis, M.D., Brinton, L.A., Devesa, S.S. Breast Cancer Res. Treat. (2004) [Pubmed]
  16. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Anderson, W.F., Chu, K.C., Chang, S., Sherman, M.E. Cancer Epidemiol. Biomarkers Prev. (2004) [Pubmed]
  17. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?. Anderson, W.F., Chu, K.C., Chang, S. J. Clin. Oncol. (2003) [Pubmed]
  18. Colorectal cancer screening for persons at average risk. Anderson, W.F., Guyton, K.Z., Hiatt, R.A., Vernon, S.W., Levin, B., Hawk, E. J. Natl. Cancer Inst. (2002) [Pubmed]
  19. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Anderson, W.F., Chatterjee, N., Ershler, W.B., Brawley, O.W. Breast Cancer Res. Treat. (2002) [Pubmed]
  20. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. Anderson, W.F., Chu, K.C., Chatterjee, N., Brawley, O., Brinton, L.A. J. Clin. Oncol. (2001) [Pubmed]
WikiGenes - Universities